Edgen Stock·Sep 20 2025, 10:24Back
European Union Grants Approval for TRYNGOLZA in Familial Chylomicronemia Syndrome
Edgen Stock·Sep 20 2025, 10:24
[1] TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS) (https://finance.yahoo.com/news/tryngolza-olez ...)[2] The Impact of EU Approval for Ionis Pharmaceuticals' Familial Chylomicronemia Treatment on Sobi's Growth Trajectory - AInvest (https://vertexaisearch.cloud.google.com/groun ...)[3] EU approves Ionis and Sobi's FCS treatment Tryngolza By Investing.com (https://vertexaisearch.cloud.google.com/groun ...)
